STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update
08 Maio 2024 - 9:15AM
STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ:
SSKN), a medical technology company dedicated to developing,
commercializing, and marketing innovative products for the
treatment of dermatologic conditions, announces that it will report
first quarter 2024 financial results on Wednesday, May 15, 2024
after the market close.
STRATA management will host a conference call at
4:30 p.m. ET on Wednesday, May 15, 2024 to review financial results
and provide an update on corporate developments. Following
management’s formal remarks, there will be a question-and-answer
session.
To listen to the conference call, interested
parties within the U.S. should dial 1-877-270-2148 (domestic) or
1-412-902-6510 (international). All callers should dial in
approximately 10 minutes prior to the scheduled start time and ask
to be joined into the STRATA Skin Sciences, Inc. conference
call.
The conference call will also be available
through a live webcast that can be accessed at STRATA Skin Sciences
1Q24 Earnings Webcast.
The webcast replay will be available until
November 15, 2024 and can be accessed through the above link.
About STRATA Skin Sciences,
Inc.STRATA Skin Sciences is a medical technology company
dedicated to developing, commercializing, and marketing innovative
products for the in-office treatment of various dermatologic
conditions, such as psoriasis, vitiligo, and acne. Its products
include the XTRAC® excimer laser, VTRAC® lamp systems,
and the TheraClear®X Acne Therapy System.
STRATA is proud to offer these exciting
technologies in the U.S. through its unique Partnership Program.
STRATA’s popular partnership approach includes a fee per treatment
cost structure versus an equipment purchase, installation and use
of the device, on-site training for practice personnel, service and
maintenance of the equipment, dedicated account and customer
service associates, and co-op advertising support to help raise
awareness and promote the program within the practice.
Safe HarborThis press release
includes "forward-looking statements" within the meaning of the
Securities Litigation Reform Act of 1995. These statements include
but are not limited to the Company’s plans, objectives,
expectations and intentions and may contain words such as “will,”
“may,” “seeks,” and “expects,” that suggest future events or
trends. These statements, the Company’s ability to launch and sell
products recently acquired or to be developed in the future, the
Company’s ability to develop social media marketing campaigns,
direct to consumer marketing campaigns, and the Company’s ability
to build a leading franchise in dermatology and aesthetics, are
based on the Company’s current expectations and are inherently
subject to significant uncertainties and changes in circumstances.
Actual results may differ materially from the Company’s
expectations due to financial, economic, business, competitive,
market, regulatory, adverse market conditions labor supply
shortages, or supply chain interruptions resulting from fiscal,
political factors, international conflicts, responses, or
conditions affecting the Company, the medical device industry and
our customers and patients in general, as well as more specific
risks and uncertainties set forth in the Company’s SEC reports on
Forms 10-Q and 10-K. Given such uncertainties, any or all these
forward-looking statements may prove to be incorrect or unreliable.
The statements in this press release are made as of the date of
this press release, even if subsequently made available by the
Company on its website or otherwise. The Company does not undertake
any obligation to update or revise these statements to reflect
events or circumstances occurring after the date of this press
release. The Company urges investors to carefully review its SEC
disclosures available
at www.sec.gov and www.strataskinsciences.com.
Investor Contact:CORE
IR516-222-2560IR@strataskin.com
Strata Skin Sciences (NASDAQ:SSKN)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Strata Skin Sciences (NASDAQ:SSKN)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024